GIGB Congressional Stock Trades
Goldman Sachs Access Investment Grade Corporate Bond ETF
Last disclosed trade Sep 9
Every disclosed trade in GIGB by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
John Boozman · Bought $GIGB · May 27 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $GIGB
Get notified when any member of Congress trades $GIGB. Free, no card, no spam.
The record on $GIGB
Coldpine has parsed 5 disclosed trades in $GIGB by 1 member of Congress, drawn from 4 periodic transaction reports dated Jan 23, 2026 through Sep 9, 2026. All of them came from senators, all filed by Republicans.
Of the 5 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 28 days. The longest was 42 days: a $GIGB purchase by John Boozman dated Sep 9, 2026, disclosed Oct 21, 2026. How late filing is measured across all of Congress is in the late-filers study.
5 of the 5 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Across the 5 purchases Coldpine can price, $GIGB moved +0.13% on average between the trade date and the disclosure date, against -0.22% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 60% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.
Members who trade GIGB
Recent disclosed trades in GIGB
| Date | Member | Type | Amount |
|---|---|---|---|
| Sep 9 | John Boozman(AR) | buy | $1K–$15K |
| May 27 | John Boozman(AR) | buy | $1K–$15K |
| May 13 | John Boozman(AR) | buy | $1K–$15K |
| Feb 6 | John Boozman(AR) | buy | $1K–$15K |
| Jan 23 | John Boozman(AR) | buy | $1K–$15K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →